Cer(d18:1/22:0)
|
Basic information |
| Metabolite name | Cer(d18:1/22:0) |
 | HMDB0004952 |
 |
C00195 |
 |
5283567 |
| Synonyms | NA |
| No. of studies | 4 |
|
Basic information |
| Metabolite name | Cer(d18:1/22:0) |
| HMDB0004952 |
|
C00195 |
|
5283567 |
| Synonyms | NA |
| No. of studies | 4 |
|
Relationship between Cer(d18:1/22:0) and depression (count: 4) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M122 | Type3 | maprotiline group vs. control group | Prefrontal cortex | BALB/c mouse | Up |
| Study M122 | Type3 | paroxetine group vs. control group | Prefrontal cortex | BALB/c mouse | Up |
| Study M123 | Type3 | rTMS group vs. control group | Prefrontal cortex | Wistar rat | Up |
| Study M613 | Type1 | CSDS susceptible group vs. control group | Nucleus accumbens | C57BL/6 J mouse | Down |
| Study M962 | Type2 | 24h-post ketamine infusion vs. baseline | Plasma | Human | Up |